Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration

Last 30 days: 62 accesses
Last 365 days: 876 accesses
All time: 4135 accesses

Susan F Hurley^*, Jane P Matthews and Robyn H Guymer

Cost Effectiveness and Resource Allocation 2008, 6:12 doi:10.1186/1478-7547-6-12

Accesses